Skip to main content

Table 1 Comparisons of clinical characteristics and outcomes among all SCAP patients

From: Clinical characteristics and risk factors associated with mortality in patients with severe community-acquired pneumonia and type 2 diabetes mellitus

Variables

Overall (n = 3786)

SCAP patients without T2DM (n = 2524)

SCAP patients with T2DM (n = 1262)

P value

Demographic characteristics

 Age (years old)

66.00 (53.00, 76.00)

66.00 (53.00, 76.00)

66.00 (53.00, 76.00)

0.934

 Sex: male (%)

2438 (64.4)

1636 (64.8)

802 (63.5)

0.464

Comorbidities

 Cancer (%)

679 (17.9)

449 (17.8)

230 (18.2)

0.776

 Chronic hematological diseases (%)

71 (1.9)

45 (1.8)

26 (2.1)

0.641

 Chronic hepatic diseases (%)

99 (2.6)

62 (2.5)

37 (2.9)

0.45

 Chronic renal diseases (%)

251 (6.6)

161 (6.4)

90 (7.1)

0.42

 Chronic cardiovascular diseases (%)

606 (16)

394 (15.6)

212 (16.8)

0.37

 Hypertension (%)

1050 (27.7)

704 (27.9)

346 (27.4)

0.788

 Chronic pulmonary diseases (%)

919 (24.3)

597 (23.7)

322 (25.5)

0.223

 Chronic cerebrovascular diseases (%)

100 (2.6)

64 (2.5)

36 (2.9)

0.641

Primary symptoms

 Fever (%)

856 (22.6)

580 (23.0)

276 (21.9)

0.467

 Cough (%)

1233 (32.6)

847 (33.6)

386 (30.6)

0.071

 Expectoration (%)

427 (11.3)

300 (11.9)

127 (10.1)

0.106

 Dyspnea (%)

731 (19.3)

510 (20.2)

221 (17.5)

0.053

 Coma (%)

751 (19.8)

528 (20.9)

223 (17.7)

0.02

 Insanity (%)

73 (1.9)

54 (2.1)

19 (1.5)

0.226

 Chest pain (%)

94 (2.5)

65 (2.6)

29 (2.3)

0.685

Vital signs on admission

 Respiratory rate (breath/min)

18.00 (15.00, 23.00)

18.00 (14.00, 22.00)

19.00 (16.00, 23.00)

< 0.001

 Systolic blood pressure (mmHg)

130.00 (111, 148)

128.00 (113.25, 146)

130.00 (110, 148)

0.238

 Diastolic blood pressure (mmHg)

72.00 (61.00, 85.00)

72.00 (61.00, 85.00)

73.00 (62.25, 83.00)

0.843

 Temperature (°C)

36.60 (36.30, 37.20)

36.60 (36.30, 37.10)

36.80 (36.30, 37.40)

< 0.001

 Heart rate (beat/min)

96.00 (81.00, 110)

96.00 (80.00, 108.00)

98.00 (87.00, 115.00)

< 0.001

Laboratory examinations

 Glucose (mmol/L)

7.36 (5.95, 10.86)

6.84 (5.50, 7.93)

12.61 (10.29, 15.30)

< 0.001

 HbA1c (%)

5.99 (4.76, 8.69)

5.40 (4.40, 6.34)

10.08 (8.23, 12.24)

< 0.001

 CRP (mg/L)

64.80 (18.5, 122.00)

61.5 (17.40, 118)

70.2 (21.9, 127)

0.002

 Procalcitonin (µg/L)

0.33 (0.14, 1.08)

0.33 (0.13, 0.89)

0.35 (0.16, 1.60)

< 0.001

 D-dimer (mg/L)

4.12 (2.17, 8.79)

4.12 (2.15, 8.33)

4.25 (2.20, 9.63)

0.012

 Lactate (mmol/L)

1.40 (1.10, 2.20)

1.40 (1, 2.1)

1.60 (1.10, 2.40)

< 0.001

 BNP (pg/mL)

1099 (329,3902)

978 (290, 3570)

1339 (397, 5067)

< 0.001

 APTT (s)

31.80 (27.60, 38.40)

31.60 (27.40, 37.80)

32.40 (28.02, 39.48)

0.004

 PT (s)

12.90 (11.90, 14.50)

12.80 (11.80, 14.30)

13.20 (12.10, 14.90)

< 0.001

 Fibrinogen (g/L)

3.57 (2.64, 4.77)

3.52 (2.60, 4.64)

3.82 (2.77, 4.96)

< 0.001

 INR

1.12 (1.03, 1.27)

1.11 (1.02, 1.25)

1.15 (1.05, 1.29)

< 0.001

 White blood cell (×109/L)

9.77 (6.72, 13.81)

9.30 (6.55, 13.31)

10.77 (7.14, 14.69)

< 0.001

 Hemoglobin (g/L)

109.00 (89.00, 129)

111.00 (90.00, 131)

106.00 (86.00, 125)

< 0.001

 Neutrophil (×109/L)

7.81 (5.01, 11.54)

7.70 (5.01, 11.31)

8.06 (5.03, 12.18)

0.009

 Lymphocyte (×109/L)

0.90 (0.56, 1.35)

0.90 (0.57, 1.34)

0.90 (0.55, 1.35)

0.995

 Platelet (×109/L)

175.00 (111, 254)

178 (114, 256)

165 (103, 252)

0.021

 Monocyte (×109/L)

0.42 (0.27, 0.63)

0.43 (0.28, 0.63)

0.40 (0.23, 0.62)

0.001

 ALT (IU/L)

22.00 (14.00, 43.00)

21.50 (13.00, 41.00)

23.00 (14.00, 45.00)

0.012

 AST (IU/L)

29.00 (20.00, 51.00)

28.00 (20.00, 49.00)

30.00 (20.00, 55.00)

0.045

 Creatinine (µmol/L)

73.00 (55, 107.25)

71.00 (54.00, 98.00)

79.00 (58.00, 133.75)

< 0.001

 Uric acid (µmol/L)

236.00 (148, 343)

232.80 (144, 336)

241.00 (156, 364)

0.002

 Albumin (g/L)

32.10 (28.00, 37.58)

32.7 (28.40, 38.50)

30.8 (27.30, 35.77)

< 0.001

 Globulin (g/L)

25.20 (21.60, 29.00)

25.30 (21.70, 29.02)

25.00 (21.50, 28.90)

0.255

 BUN (mmol/L)

7.10 (5.00, 11.40)

6.68 (4.71, 10.17)

8.55 (5.56, 14.65)

< 0.001

 Total bilirubin (µmol/L)

11.80 (7.90, 17.80)

12.2 (8.2, 18.2)

10.8 (7.12, 16.7)

< 0.001

 Direct bilirubin (µmol/L)

5.50 (3.50, 9.00)

5.40 (3.50, 9.00)

5.60 (3.50, 8.90)

0.647

Clinical outcomes

 ICU LOS (days)

12.00 (6.00, 23.00)

12.00 (5.00, 22.00)

13.00 (6.00, 24.00)

0.016

 Hospital LOS (days)

21.00 (12.00, 33.00)

21.00 (13.00, 32.00)

20.50 (11.00, 34.00)

0.168

 Need for CPR during hospitalization (%)

120 (3.2)

72 (2.9)

48 (3.8)

0.115

 Death within 14 days (%)

461  (12.2)

272 (10.8)

189 (15)

< 0.001

 Death within 30 days (%)

898 (23.7)

574 (22.7)

324 (25.7)

0.046

 ICU mortality (%)

1058 (27.9)

669 (26.5)

389 (30.8)

0.005

 Hospital mortality (%)

1226 (32.4)

782 (31.0)

444 (35.2)

0.009

  1. Data are shown as median with interquartile range (IQR) for continuous variables or number with percentage for categorical variables
  2. SCAP Severe community-acquired pneumonia, n numbers, T2DM type 2 diabetes mellitus, CRP C-reactive protein, BNP brain natriuretic peptide, APTT activated partial thromboplastin time, PT prothrombin time, INR international normalized ratio, ALT alanine aminotransferase, AST aspartate aminotransferase, BUN blood urea nitrogen, ICU intensive care unit, LOS length of stay, CPR cardiac pulmonary resuscitation